Alexandria Real Estate Equities (NYSE:ARE) Given New $50.00 Price Target at Royal Bank Of Canada

Posted by Brenda Bartman on May 5th, 2026

Alexandria Real Estate Equities (NYSE:ARE – Get Free Report) had its price target reduced by analysts at Royal Bank Of Canada from $60.00 to $50.00 in a report issued on Tuesday,MarketScreener reports. The firm presently has a “sector perform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price target indicates a potential upside of 20.79% from the company’s previous close.

Other research analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Alexandria Real Estate Equities from $53.00 to $55.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Mizuho decreased their price target on shares of Alexandria Real Estate Equities from $91.00 to $70.00 and set an “outperform” rating for the company in a research report on Friday, January 9th. The Goldman Sachs Group started coverage on shares of Alexandria Real Estate Equities in a research note on Tuesday, February 3rd. They set a “neutral” rating and a $60.00 price target for the company. Jefferies Financial Group cut their price target on shares of Alexandria Real Estate Equities from $57.00 to $47.00 and set a “hold” rating on the stock in a report on Tuesday, April 14th. Finally, Cantor Fitzgerald reduced their price objective on shares of Alexandria Real Estate Equities from $60.00 to $43.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 29th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Alexandria Real Estate Equities has an average rating of “Hold” and an average price target of $51.92.

Get Our Latest Research Report on ARE

Alexandria Real Estate Equities Trading Up 0.6%

Shares of ARE stock opened at $41.39 on Tuesday. Alexandria Real Estate Equities has a twelve month low of $39.41 and a twelve month high of $88.24. The stock’s fifty day simple moving average is $47.90 and its 200 day simple moving average is $52.48. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $7.21 billion, a P/E ratio of -6.59, a P/E/G ratio of 5.01 and a beta of 1.12.

Alexandria Real Estate Equities (NYSE:ARE – Get Free Report) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $1.73 EPS for the quarter, meeting the consensus estimate of $1.73. The firm had revenue of $671.02 million during the quarter, compared to the consensus estimate of $684.78 million. Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.03%.The business’s quarterly revenue was down 11.5% on a year-over-year basis. During the same period last year, the company earned $2.30 earnings per share. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.300-6.500 EPS. As a group, sell-side analysts predict that Alexandria Real Estate Equities will post 6.4 EPS for the current fiscal year.

Insider Transactions at Alexandria Real Estate Equities

In other news, EVP Gregory Calvin Thomas bought 3,500 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average price of $41.00 per share, with a total value of $143,500.00. Following the completion of the purchase, the executive vice president directly owned 33,024 shares of the company’s stock, valued at approximately $1,353,984. This represents a 11.85% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Hallie E. Kuhn sold 536 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $48.20, for a total transaction of $25,835.20. Following the completion of the transaction, the executive vice president owned 48,301 shares in the company, valued at approximately $2,328,108.20. The trade was a 1.10% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.35% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Alexandria Real Estate Equities

Large investors have recently added to or reduced their stakes in the business. Avalon Trust Co bought a new stake in Alexandria Real Estate Equities in the third quarter worth approximately $29,000. Cornerstone Planning Group LLC boosted its holdings in shares of Alexandria Real Estate Equities by 5,916.7% during the 3rd quarter. Cornerstone Planning Group LLC now owns 361 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 355 shares in the last quarter. BOKF NA grew its position in shares of Alexandria Real Estate Equities by 6,033.3% during the 3rd quarter. BOKF NA now owns 368 shares of the real estate investment trust’s stock worth $31,000 after buying an additional 362 shares during the period. CYBER HORNET ETFs LLC bought a new stake in shares of Alexandria Real Estate Equities in the 2nd quarter valued at $30,000. Finally, CIBC Private Wealth Group LLC increased its stake in shares of Alexandria Real Estate Equities by 109.6% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 436 shares of the real estate investment trust’s stock valued at $36,000 after acquiring an additional 228 shares in the last quarter. Institutional investors and hedge funds own 96.54% of the company’s stock.

About Alexandria Real Estate Equities

(Get Free Report)

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.